SAN DIEGO, April 25, 2023 /PRNewswire/ — Halozyme Therapeutics, Inc. (NASDAQ: HALO) (“Halozyme”) today announced it will release its first quarter 2023 financial and operating results on Tuesday, May 9, 2023, following the close of trading. Halozyme will host a conference call on Tuesday, May 9, 2023 at 4:30 p.m.…Read More
Halozyme To Report First Quarter 2023 Financial and Operating Results
